DrugInformer Search

Neurontin Related Impulsive behaviour

Official Government Database Reports29
Online Conversations2

Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients. To view the active ingredient report, please click here.

Tell us about your Experience with Neurontin

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: Hypersomnia, Nightmare, Crying, Mood altered, Suicidal behaviour, Impulsive behaviour, Energy increased

Posted By Anonymous in askapatient.com on January 16, 2012 @ 12:00 am

Side Effects: Initially I experienced improved sleep and improved ability to fall asleep. Then I had a few days in which my pain was greatly reduced, had a lot more energy, and my mood was elevated ...

Druginformer Identified Side Effects: Fatigue, Memory impairment, Amnesia, Disturbance in attention, Drug ineffective, Weight increased, Psychotic disorder, Social problem, Opiates, Attention deficit/hyperactivity disorder, Impulsive behaviour

Posted By Anonymous in askapatient.com on March 1, 2007 @ 12:00 am

Side Effects: Superior oblique myokymia--worked wonders for a month, then quit. Upping dose was no help. Side effects began after a month--fatigue and adhd. Later, took it for back pain (3 months) ...

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.